Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathwayXiaoyang Liu, Ling Jing, Shuping Yang et al.|Molecular Medicine Reports|2014Cited by 37